CHRS Net Income Growth
Coherus Oncology Inc · Net Income Growth
CHRS Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported17.82%period ending
CHRS TTM Net Income YoY % (-62.46% → 17.82%)
Year-over-year change
High-resolution chart · PNG
CHRS net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 17.8185% | |
| -15.8275% | |
| -697.3656% | |
| -40,724.2222% | |
| -443.1186% | |
| -120.8491% | |
| 111.9832% | |
| 99.7927% | |
| 88.8913% | |
| 78.1547% | |
| 18.4614% | |
| 22.0739% | |
| -14.5913% | |
| -29.0919% | |
| -1.621% | |
| -20.2627% | |
| -39.5149% | |
| -175.6303% | |
| -317.0987% | |
| -243.2138% | |
| -191.3381% | |
| -152.4555% | |
| 47.2109% | |
| 1,449.1493% | |
| 253.489% | |
| 178.5799% | |
| 142.9127% | |
| 93.8767% | |
| 39.8743% | |
| 10.9024% | |
| 12.1052% | |
| 26.1161% | |
| -60.522% | |
| -51.9005% | |
| -87.0391% | |
| -155.3046% | |
| 52.8732% | |
| 44.851% | |
| 42.9647% | |
| 48.0973% | |
| -89.7452% | |
| -141.4333% | |
| -156.229% | |
| -175.5242% | |
| -58.4168% | |
| -46.8167% | |
| -62.4555% |